Health in Russia 1,157 indicators covering health for Russia. IndicatorLatest Year10-yr change Rank Mean systolic blood pressure 130.5 2009 up 0.1% 26th Mean fasting blood glucose (mmol/l) 5.6 2009 up 1.8% 30th Hiv expenditure 703.04 million 2017 up 130.5% 5th Infant mortality rates 3.3 2013 down 23.3% 7th Prevalence of overweight, weight for height 16.9% 2005 down 2.3% 2nd Most sold brand of cigarettes - price in currency reported 158 2020 up 409.7% 65th Most sold brand of cigarettes - taxes as a % of price - total tax 0.6% 2020 up 60.0% 88th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.1% 2020 up 114.3% 70th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 up 13.3% 19th Most sold brand of cigarettes - taxes as a % of price - specific 0.2% 2020 up 92.3% 88th Most sold brand of cigarettes - price in US$ at official exchange 2.15 2020 up 108.7% 112th Number healthy diet unaffordable 1.80 million 2024 down 60.0% 76th Import of environmentally sound technologies 22.75 billion 2020 up 14.2% 14th Most sold brand of cigarettes - price in PPP$ 6.07 2020 up 219.5% 87th Export of environmentally sound technologies 6.31 billion 2020 up 73.0% 30th Pcv3 number unvaccinated 96,787 2023 down 92.3% 38th Health risks - Regions — Respiratory system diseases mortality crude 40 Per 100 000 inhabitants 2019 down 27.3% 36th Gross national income per capita 39,222 2023 up 7.1% 35th Health risks - Regions — Circulatory system diseases mortality crude 565 Per 100 000 inhabitants 2019 down 28.4% 8th Reported number of human rabies deaths 7 2020 down 53.3% 29th Life expectancy by age and sex 68.9 2010 — 44th Crude death rate hmd 12.97 2014 down 17.8% 7th Births and deaths 12.97 2014 down 17.8% 7th Period versus cohort life expectancy 70.92 2014 up 8.7% 41st Annual death rate by age group 7.46 2014 down 37.1% 2nd Prevalence of wasting, weight for height, female 4.0% 2005 down 9.1% 43rd Prevalence of wasting, weight for height, male 2.7% 2005 down 37.2% 62nd Percentage of all children enrolled in private institutions of 1.55 2019 — 66th Number reported cases of cholera 1 2014 unchanged 85th Human Development Index 0.832 2023 up 0.2% 46th Prevalence of severe wasting, weight for height, female 2.0% 2005 up 81.8% 11th Prevalence of severe wasting, weight for height, male 0.6% 2005 down 66.7% 60th Prevalence of overweight, weight for height, female 15.4% 2005 up 22.2% 1st Prevalence of overweight, weight for height, male 18.2% 2005 down 18.0% 1st Life expectancy at birth oecd 73.2 2019 up 6.4% 41st How many health warnings are approved by the law for cigarette 12 2022 down 7.7% 48th Tuberculosis - new and relapse cases 112,910 2011 down 14.8% 10th Number of reported cholera deaths 0 2014 — 37th Physiotherapists 4,545 2020 down 18.2% 34th Generalist medical practitioners 47,573 2019 down 36.4% 13th Percentage of principal display area mandated to be covered by health 50 2022 up 25.0% 80th Average of 13 International Health Regulations core capacity scores 98 2016 up 4.3% 13th New cases: pulmonary smear-negative 59,019 2012 down 35.0% 8th Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 73rd Percentage of principal display area mandated to be covered by health 50 2022 unchanged 80th Average death rate due to natural disasters 0.3646 2021 down 33.9% 69th Total number of notified TB cases 136,168 2014 down 10.7% 9th The number of people with susceptibility test result for rifampicin 21,391 2021 — 15th Specialist medical practitioners 428,217 2014 up 52.7% 2nd New cases: pulmonary smear unknown/not done 1,039 2012 — 25th Smear-positive tuberculosis treatment-success rate 54.0% 2011 down 19.4% 174th How many health warnings are approved by the law for other smoked 12 2022 down 7.7% 49th Insufficiently active 84.53 2016 up 0.8% 54th Percentage of principal display area mandated to be covered by health 50 2022 up 25.0% 67th The number of people with susceptibility test result for rifampicin 93.52 2021 — 57th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 65th Medical doctors 70.8% 2020 up 0.7% 7th ← Previous Page 18 of 20 Next →